Harrington Robert Arthur bought CYTK
July 15, 2025 · Form 4 insider transaction
Harrington Robert Arthur bought 328 shares of Cytokinetics, Incorporated at $38.01 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
328
Price
$38.01
Total value
$12.5K
InsiderHarrington Robert Arthur
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2025
Filing dateJuly 16, 2025
Shares owned after22,643
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director equity in lieu of cash retainer program.